We are live on ! Find out more
GS

Gagnon Securities Portfolio holdings

AUM $519M
1-Year Est. Return 44.91%
This Fund
S&P 500
This Quarter Est. Return
+11.64%
1 Year Est. Return
+44.91%
3 Year Est. Return
+129.38%
5 Year Est. Return
+108.07%
10 Year Est. Return
+1,389.15%
AUM
$453M
AUM Growth
-$1.88M
Cap. Flow
+$106M
Cap. Flow %
23.5%
Top 10 Hldgs %
47.3%
Holding
110
New
9
Increased
39
Reduced
57
Closed
5

Top Buys

Rank Stock Value
1
ZM icon
Zoom
ZM
+$66.3M
2
WLY icon
John Wiley & Sons Class A
WLY
+$59.5M
3
TPR icon
Tapestry
TPR
+$7.52M
4
CDNA icon
CareDx
CDNA
+$3M
5
FIVN icon
FIVE9
FIVN
+$2.87M

Sector Composition

Rank Sector Weight
1 Healthcare 34.18%
2 Technology 17.58%
3 Industrials 16.18%
4 Energy 11.1%
5 Consumer Discretionary 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AL
1
DELISTED
Air Lease Corp
AL
$35.4M 7.82%
921,417
-14,696
-2% -$529K
ENSG icon
2
The Ensign Group
ENSG
$10.4B
$30.6M 6.75%
323,180
-2,169
-0.7% -$197K
PCRX icon
3
Pacira BioSciences
PCRX
$979M
$21.8M 4.8%
563,415
-11,193
-2% -$545K
NVGS icon
4
Navigator Holdings
NVGS
$1.27B
$21.6M 4.78%
1,808,683
-71,021
-4% -$863K
PROF
5
Profound Medical
PROF
$290M
$19.4M 4.28%
1,778,205
+11,350
+0.6% +$61.9K
EPD icon
6
Enterprise Products Partners
EPD
$81.6B
$18.5M 4.09%
767,247
-12,748
-2% -$314K
ISRG icon
7
Intuitive Surgical
ISRG
$133B
$17.9M 3.95%
67,483
-69
-0.1% -$16.8K
CDNA icon
8
CareDx
CDNA
$2.35B
$17.1M 3.77%
1,495,746
+202,136
+16% +$3M
APEN
9
DELISTED
Apollo Endosurgery, Inc.
APEN
$17M 3.75%
1,703,175
-83,310
-5% -$621K
EVA
10
DELISTED
Enviva Inc.
EVA
$15M 3.32%
283,982
+968
+0.3% +$55.3K
AMRC icon
11
Ameresco
AMRC
$1.36B
$15M 3.32%
263,149
-3,330
-1% -$203K
FIVN icon
12
FIVE9
FIVN
$2.27B
$13.6M 3%
200,538
+45,742
+30% +$2.87M
BL icon
13
BlackLine
BL
$1.79B
$13.1M 2.88%
194,047
-658
-0.3% -$40.8K
NEWR
14
DELISTED
New Relic, Inc.
NEWR
$12.3M 2.72%
218,339
+1,990
+0.9% +$113K
EQIX icon
15
Equinix
EQIX
$104B
$10.9M 2.4%
16,603
-68
-0.4% -$42K
AOSL icon
16
Alpha and Omega Semiconductor
AOSL
$974M
$10.2M 2.26%
357,763
-2,519
-0.7% -$81.5K
BLFS icon
17
BioLife Solutions
BLFS
$1.65B
$10.2M 2.25%
561,062
-3,301
-0.6% -$68.2K
WLY icon
18
John Wiley & Sons Class A
WLY
$2.76B
$9.4M 2.07%
1,438,934
+1,422,296
+8,548% +$59.5M
KMX icon
19
CarMax
KMX
$8.04B
$9.04M 2%
148,515
-3,784
-2% -$243K
ETWO
20
DELISTED
E2open Parent Holdings
ETWO
$8.78M 1.94%
1,496,249
-191,363
-11% -$1.1M
QDEL icon
21
QuidelOrtho
QDEL
$1.19B
$8.59M 1.9%
100,274
-12,266
-11% -$1.04M
FRSH icon
22
Freshworks
FRSH
$3.18B
$7.96M 1.76%
541,097
-1,528
-0.3% -$21.2K
CMG icon
23
Chipotle Mexican Grill
CMG
$43.7B
$7.73M 1.71%
278,400
+300
+0.1% +$8.96K
EVBG
24
DELISTED
Everbridge, Inc. Common Stock
EVBG
$6.69M 1.48%
226,303
-41,724
-16% -$1.28M
SCWX
25
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$6.55M 1.45%
1,025,697
+482
+0% +$3.4K

Similar funds

Gagnon Securities's Q4 2022 Portfolio in Review

As of Q4 2022, Gagnon Securities held 110 positions worth $453M, down 0.41% from $455M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Gagnon Securities deployed $106M of net new capital in Q4 2022, opening 9 new positions and adding to 39 existing holdings. Its largest new stake was DermTech, Inc. Common Stock: 159,407 shares worth $282K.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 33% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Yext, an estimated $9.67M trimmed.

  • Gagnon Securities's largest Q4 2022 buy was DermTech, Inc. Common Stock: 159,407 shares worth $282K.
  • Gagnon Securities added most to Zoom in Q4 2022, an estimated $66.3M increase.
  • Gagnon Securities's biggest Q4 2022 reduction was Yext, cutting an estimated $9.67M.
  • Gagnon Securities fully exited Zuora, Inc. in Q4 2022, selling an estimated $10.5M.
  • Gagnon Securities's ten largest holdings make up 47% of its $453M portfolio in Q4 2022.
  • Gagnon Securities opened 9 new positions and closed 5 in Q4 2022.
  • Gagnon Securities's portfolio value fell 0.41% quarter-over-quarter to $453M.

Based on Gagnon Securities's 13F filing for Q4 2022, filed 7 Feb 2023.